• Parkinson’s Research

  Parkinson’s Patients Get Higher AXO-Lenti-PD Dose in Gene Therapy Trial

  Posted by Community Member on June 17, 2020 at 9:57 am

  

  Axovant announced four adults were given a higher dose of its gene therapy, AXO-Lenti-PD, as the first part of the SUNRISE-PD trial continues in Europe. Read the full story here.

  What do you think of this news?

  Community Member replied 5 years, 11 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply